Toward biosimilar monoclonal antibodies

Toward biosimilar monoclonal antibodies

To what extent is the existing framework for biosimilars in Europe likely to be applicable to monoclonal antibodies?

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature biotechnology 2008-09, Vol.26 (9), p.985-990
Hauptverfasser: Schneider, Christian K, Kalinke, Ulrich
Format: Artikel
Sprache:eng
Schlagworte:
Agriculture
Antibodies, Monoclonal - chemistry
Antibodies, Monoclonal - immunology
Antibody Specificity - immunology
Biochemistry
Bioinformatics
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedical Research
Biomedicine
Biotechnology
Chemistry, Pharmaceutical - legislation & jurisprudence
Chemistry, Pharmaceutical - methods
commentary
Committees
Drug Approval
Drug Design
Drug Industry - legislation & jurisprudence
Drug Industry - methods
Drug Industry - trends
Europe
Humans
Life Sciences
Pharmaceutical industry
R&D
Regulation
Research & development
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To what extent is the existing framework for biosimilars in Europe likely to be applicable to monoclonal antibodies?
ISSN:1087-0156
1546-1696
DOI:10.1038/nbt0908-985